Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

S100A8 and S100A9 are Ca2+ binding proteins that belong to the S100 family. Primarily expressed in neutrophils and monocytes, S100A8 and S100A9 play critical roles in modulating various inflammatory responses and inflammation-associated diseases. Forming a common heterodimer structure S100A8/A9, S100A8 and S100A9 are widely reported to participate in multiple signaling pathways in tumor cells. Meanwhile, S100A8/A9, S100A8, and S100A9, mainly as promoters, contribute to tumor development, growth and metastasis by interfering with tumor metabolism and the microenvironment. In recent years, the potential of S100A8/A9, S100A9, and S100A8 as tumor diagnostic or prognostic biomarkers has also been demonstrated. In addition, an increasing number of potential therapies targeting S100A8/A9 and related signaling pathways have emerged. In this review, we will first expound on the characteristics of S100A8/A9, S100A9, and S100A8 in-depth, focus on their interactions with tumor cells and microenvironments, and then discuss their clinical applications as biomarkers and therapeutic targets. We also highlight current limitations and look into the future of S100A8/A9 targeted anti-cancer therapy. Copyright © 2023 Elsevier B.V. All rights reserved.


Yu Chen, Yuzhen Ouyang, Zhixin Li, Xiufang Wang, Jian Ma. S100A8 and S100A9 in Cancer. Biochimica et biophysica acta. Reviews on cancer. 2023 May;1878(3):188891

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 37001615

View Full Text